UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000031616
Receipt No. R000036091
Official scientific title of the study Photodynamic diagnosis for upper urinary tract carcinoma using 5-ALA
Date of disclosure of the study information 2018/04/01
Last modified on 2018/03/06 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Photodynamic diagnosis for upper urinary tract carcinoma using 5-ALA
Title of the study (Brief title) PDD for UUTC
Region
Japan

Condition
Condition Upper urinary tract carcinoma
Classification by specialty
Urology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Discovery reseach
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Positive subject rates
Key secondary outcomes Sensitivity, specificity

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Medicine
Interventions/Control_1 Photodynaminc diagnosis for upper urinary tract carcinoma after ALA administration.
ALA: 20mg/kg
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >=
Gender Male and Female
Key inclusion criteria 1. Age-lower limit; >20 year-old
2. Suspicious of upper urinary tract carcinoma
3. To agree informed concent
4. To sign agreement document
Key exclusion criteria 1. Hypersensitivity for ALA
2. Porphyria patients
3. Severe infectious disease
4. Severe complication
Target sample size 10

Research contact person
Name of lead principal investigator Inoue Keiji
Organization Kochi Medical School
Division name Department of urology
Address Oko, Nankoku, Kochi prefecture
TEL 088-880-2402
Email keiji@kochi-u.ac.jp

Public contact
Name of contact person Fukuhara Hideo
Organization Kochi medical school
Division name Department of urology
Address Oko, Nankoku, Kochi prefecture
TEL 088-880-2402
Homepage URL
Email jm-fukuhara@kochi-u.ac.jp

Sponsor
Institute Kochi medical school, department of urology
Institute
Department

Funding Source
Organization Kochi medical school, department of urology
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 04 Month 01 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2017 Year 12 Month 26 Day
Anticipated trial start date
2018 Year 04 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2018 Year 03 Month 06 Day
Last modified on
2018 Year 03 Month 06 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036091